Theranos Had $200 Million in Cash Left at Year-End -
The embattled blood-diagnostics firm had $ 200 million of cash on hand at the end of 2016, people familiar with the matter said, less than a quarter of the funding it raised from investors and partners. WSJ.com: US Business
We would like to welcome you to DailyBusinessNews.com a place where you can get all the top headline news every day 24/7. We are committed to bring you all the breaking news as it happens hour by hour. Our staff is dedicated and have high standards in reporting all aspects of the news from around the world.